[+ Font] :: [- Font] :: Printable

Uraniums

from ChartWorks:: published by Institutional Advisors

Bob Hoye
Technical observations of RossClark@shaw.ca
July 11th, 2005

The uranium stocks are now past the normal consolidation phase that has followed previous major rallies such as the one that ended in February. Given the right stimulus and improving money flows, the prices should now be capable of making their next move higher. For traders, risk should be limited to the June lows.

Cameco (CCO.TO) is showing signs of renewed accumulation and an initial pullback to the 20-day exponential moving average (currently $54.40) should provide support.

Denison (DEN.TO) showed some signs of upside action early this week with increased volume, but needs to close over $17 to confirm a breakout.

International Uranium Corp (IUC.TO) needs to close over $5.75 on expanding volume to confirm a breakout.

UEX Corp (UEX.TO) is holding at support, but needs to close over $1.80 to have a chance of turning this into a base.

Bob Hoye
July 11th, 2005

EMAIL:: bobhoye@institutionaladvisors.com
CHARTWORKS WEBSITE:: www.institutionaladvisors.com

The opinions in this report are solely those of the author. The information herein was obtained from various sources; however we do not guarantee its accuracy or completeness. This research report is prepared for general circulation and is circulated for general information only. It does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this report. Investors should seek financial advice regarding the appropriateness of investing in any securities or investment strategies discussed or recommended in this report and should understand that statements regarding future prospects may not be realized. Investors should note that income from such securities, if any, may fluctuate and that each security’s price or value may rise or fall. Accordingly, investors may receive back less than originally invested. Past performance is not necessarily a guide to future performance. Neither the information nor any opinion expressed constitutes an offer to buy or sell any securities or options or futures contracts. Foreign currency rates of exchange may adversely affect the value, price or income of any security or related investment mentioned in this report. In addition, investors in securities such as ADRs, whose values are influenced by the currency of the underlying security, effectively assume currency risk. Moreover, from time to time, members of the Institutional Advisors team may be long or short positions discussed in our publications.